Open-label Extension Denosumab Study in Children and Young Adults With Osteogenesis Imperfecta
Osteogenesis imperfecta / Posted 3 years ago
To evaluate long-term safety of denosumab in subjects with pediatric osteogenesis imperfecta(OI) completing Study 20130173.
- Study start date : 01/07/2018
- Study end date : 01/03/2024
- Wales-Based Study Contact : please speak to your clinician